Bill > H0355

This bill expands and clarifies the use of emergency opioid antagonists in Florida's public schools and postsecondary educational institutions. The legislation broadens the definition of "emergency opioid antagonist" beyond just naloxone to include any United States Food and Drug Administration (FDA)-approved drug that can block the effects of opioids and treat overdoses. Public schools are now explicitly authorized to purchase these emergency opioid antagonists from wholesale distributors, potentially at reduced or free prices, and must store them securely on school premises. The bill provides legal protection for school district employees who administer these drugs to students during an overdose, ensuring they are immune from civil liability when acting in compliance with existing state laws. By updating these provisions, the bill aims to improve emergency response capabilities and potentially save lives in educational settings by ensuring access to medication that can rapidly counteract opioid overdoses. The changes will take effect on July 1, 2025, giving institutions time to prepare and implement the new guidelines.

Health and Social Services

https://www.flsenate.gov/Session/Bill/2025/355